We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Pediatrics

Pediatrics

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in Children: A Multicenter Clinical Study Report
GastroenterologyClinical Studygastroenterology

Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in Children: A Multicenter Clinical Study Report

By MedXY|Mar 20, 2026

This report examines the role of Intestinal Ultrasound (IUS) in pediatric Acute Severe Ulcerative Colitis (ASUC). Results from 60 patients show that IUS metrics, specifically colonic wall thickness and the Milan Ultrasound Score, can accura

Beyond the Motor Cortex: Functional Network Mapping Redefines Cerebral Palsy Prediction After Neonatal Stroke
Neurologycerebral palsyConnectomics

Beyond the Motor Cortex: Functional Network Mapping Redefines Cerebral Palsy Prediction After Neonatal Stroke

By MedXY|Mar 20, 2026

A landmark study using lesion network mapping reveals that cerebral palsy after neonatal stroke is driven by disruptions in extensive functional networks, including the thalamus and cerebellum, rather than just localized motor cortex damage

Strengthening the Safety Net: Insights from the First National Assessment of EMS Pediatric Readiness
Emergency MedicineEMSPECC

Strengthening the Safety Net: Insights from the First National Assessment of EMS Pediatric Readiness

By MedXY|Mar 14, 2026

This article examines the landmark findings from the National Pediatric Prehospital Readiness Project, identifying critical gaps in emergency care for children and highlighting the transformative role of Pediatric Emergency Care Coordinator

Bridging the Gap in Emergency Care: The National Assessment of Pediatric Readiness in EMS
Emergency Medicineemergency medicineEMS

Bridging the Gap in Emergency Care: The National Assessment of Pediatric Readiness in EMS

By MedXY|Mar 14, 2026

The first national assessment of US EMS agencies reveals a critical need for improved pediatric readiness. While equipment scores are high, significant gaps exist in quality improvement and family-centered care, with Pediatric Emergency Car

A New Standard for Pediatric Vocal Fold Immobility After Cardiac Surgery: Improving Outcomes Through Injection Laryngoplasty
CardiologyCardiothoracic SurgeryDysphagia

A New Standard for Pediatric Vocal Fold Immobility After Cardiac Surgery: Improving Outcomes Through Injection Laryngoplasty

By MedXY|Mar 13, 2026

Recent research highlights a standardized multidisciplinary protocol for managing unilateral vocal fold immobility in infants after cardiothoracic surgery, showing that injection laryngoplasty significantly improves oral feeding advancement

LC-MS/MS Redefines Accuracy in Congenital Adrenal Hyperplasia Newborn Screening: Reducing the False-Positive Burden
Diabetes & Endocrinology17-hydroxyprogesteroneCongenital Adrenal Hyperplasia

LC-MS/MS Redefines Accuracy in Congenital Adrenal Hyperplasia Newborn Screening: Reducing the False-Positive Burden

By MedXY|Mar 12, 2026

A prospective study of over 700,000 newborns demonstrates that LC-MS/MS significantly improves the positive predictive value (PPV) of CAH screening compared to traditional RIA, identifying specific steroid ratios that offer 100% PPV and red

Long-Term Thyroid Toxicity Burden in Children Who Received Treatment for High-Risk Neuroblastoma
Clinical UpdatesĐộc tính tuyến giápneuroblastoma

Long-Term Thyroid Toxicity Burden in Children Who Received Treatment for High-Risk Neuroblastoma

By MedXY|Mar 11, 2026

This review analyzes the significant long-term thyroid toxicity burden in high-risk neuroblastoma survivors, identifying key risk factors such as molecular radiotherapy, tandem myeloablative therapy, and immunotherapy.

Long-Term Reality of Single-Ventricle Reconstruction: Shunt Choice, Tricuspid Regurgitation, and the Burden of Global Morbidity
CardiologyHypoplastic Left Heart Syndromepediatric cardiology

Long-Term Reality of Single-Ventricle Reconstruction: Shunt Choice, Tricuspid Regurgitation, and the Burden of Global Morbidity

By MedXY|Mar 11, 2026

A 16-year follow-up of the SVR trial reveals that while shunt types show similar long-term outcomes overall, pre-existing tricuspid regurgitation significantly impacts survival with RVPAS, amid a staggering 87% rate of major morbidity.

Beyond Height Velocity: Longitudinal Impact of Long-Acting Growth Hormone on Body Mass Index in Pediatric Growth Hormone Deficiency
Clinical UpdatesBMIGHD

Beyond Height Velocity: Longitudinal Impact of Long-Acting Growth Hormone on Body Mass Index in Pediatric Growth Hormone Deficiency

By MedXY|Mar 11, 2026

This meta-analysis reveals that long-acting growth hormone (LAGH) is associated with a significant increase in BMI SD scores during the first year of treatment and upon switching from daily GH, suggesting a distinct metabolic profile compar

Beyond the Aorta: Genetic Stratification Redefines Mitral Valve Risk in Marfan Syndrome
CardiologyFBN1 MutationMarfan Syndrome

Beyond the Aorta: Genetic Stratification Redefines Mitral Valve Risk in Marfan Syndrome

By MedXY|Mar 11, 2026

A breakthrough study reveals that specific FBN1 genotypes, particularly in-frame variants in the DNCD region, significantly elevate the risk of early mitral valve surgery in Marfan syndrome patients, paving the way for genotype-guided clini

Twice-Yearly Inclisiran Transforms LDL-C Management in Adolescents with HeFH: Insights from ORION-16
CardiologyFamilial HypercholesterolaemiaInclisiran

Twice-Yearly Inclisiran Transforms LDL-C Management in Adolescents with HeFH: Insights from ORION-16

By MedXY|Mar 10, 2026

The ORION-16 trial demonstrates that inclisiran, a twice-yearly siRNA therapy, significantly and safely reduces LDL cholesterol in adolescents with heterozygous familial hypercholesterolaemia, offering a promising solution for long-term adh

Misaligned Urgency: Why Status Exceptions May Be Paradoxically Lowering Priority for the Sickest Children in Heart Transplantation
CardiologyCardiologyHeart Transplantation

Misaligned Urgency: Why Status Exceptions May Be Paradoxically Lowering Priority for the Sickest Children in Heart Transplantation

By MedXY|Mar 10, 2026

A large-scale analysis of 6,026 pediatric heart transplant candidates reveals that status exceptions often prioritize patients with lower mortality risk than those meeting standard criteria, highlighting a significant misalignment in the U.

Leveling the Playing Field: New Trans-Ancestry Polygenic Risk Score Transforms Type 1 Diabetes Screening
Diabetes & Endocrinologygenomicshealth equity

Leveling the Playing Field: New Trans-Ancestry Polygenic Risk Score Transforms Type 1 Diabetes Screening

By MedXY|Mar 10, 2026

Researchers have developed a trans-ancestry polygenic risk score (TA-PS) that significantly improves the accuracy of type 1 diabetes prediction across diverse ethnic groups, addressing the long-standing European bias in genetic risk assessm

Fordadistrogene Movaparvovec Fails to Improve Functional Outcomes in Duchenne Muscular Dystrophy: Insights from the Phase 3 CIFFREO Trial
NeurologyBệnh Teo Cơ Bắp DuchenneCIFFREO Trial

Fordadistrogene Movaparvovec Fails to Improve Functional Outcomes in Duchenne Muscular Dystrophy: Insights from the Phase 3 CIFFREO Trial

By MedXY|Mar 8, 2026

The Phase 3 CIFFREO trial found that the gene therapy fordadistrogene movaparvovec did not significantly improve motor function in boys with Duchenne muscular dystrophy compared to placebo, leading to the discontinuation of its clinical dev

24-Weekly vs. 12-Weekly Triptorelin: Clinical Equivalence and Enhanced Adherence in Central Precocious Puberty
Diabetes & Endocrinologycentral precocious pubertyNội Tiết Học Nhi Khoa

24-Weekly vs. 12-Weekly Triptorelin: Clinical Equivalence and Enhanced Adherence in Central Precocious Puberty

By MedXY|Mar 7, 2026

A UK multicentre study demonstrates that 24-weekly Decapeptyl SR is as effective and well-tolerated as the 12-weekly regimen for central precocious puberty, offering improved patient satisfaction and reduced clinical burden.

Deciphering ZnT8A: Why Not All Islet Autoantibodies Predict Type 1 Diabetes Risk
Diabetes & EndocrinologyIslet Autoantibodiestype 1 diabetes

Deciphering ZnT8A: Why Not All Islet Autoantibodies Predict Type 1 Diabetes Risk

By MedXY|Mar 7, 2026

The ENDIA cohort study reveals that persistent single ZnT8 autoantibodies detected only via ELISA after age 4 do not significantly increase Type 1 Diabetes risk, whereas earlier detection across multiple assay formats signals higher progres

Genetic Breakthrough: How SNUPN Gene Variants Lead to Spinocerebellar Atrophy
Neurologygeneticsneurology

Genetic Breakthrough: How SNUPN Gene Variants Lead to Spinocerebellar Atrophy

By MedXY|Mar 6, 2026

Researchers have discovered that mutations in the SNUPN gene cause spinocerebellar atrophy by disrupting RNA splicing in Purkinje cells, expanding the understanding of neurodevelopmental disorders beyond muscular conditions.

Cellular Therapy for In-Utero Myelomeningocele Repair: Results from the CuRe Phase 1 Trial
newsneurosurgeryregenerative medicine

Cellular Therapy for In-Utero Myelomeningocele Repair: Results from the CuRe Phase 1 Trial

By MedXY|Mar 6, 2026

This phase 1 study evaluates the safety of placenta-derived mesenchymal stem cells (PMSCs) seeded on an extracellular matrix for in-utero repair of myelomeningocele, demonstrating successful surgical outcomes and no cell-related adverse eve

Topical Botanical Solution Cinainu Shows Sustained Efficacy and Safety in Paediatric Alopecia Areata: Insights from the RAAINBOW Trial
Dermatologyalopecia areataclinical trials

Topical Botanical Solution Cinainu Shows Sustained Efficacy and Safety in Paediatric Alopecia Areata: Insights from the RAAINBOW Trial

By MedXY|Mar 6, 2026

The RAAINBOW phase II/III trial demonstrates that Cinainu, a topical botanical solution, significantly improves hair regrowth and quality of life in paediatric patients with moderate-to-severe alopecia areata, offering a well-tolerated alte

Unorthodox JAK Inhibitor Dosing in Pediatric Moderate-to-Severe Alopecia Areata: A Comparative Evaluation of Tofacitinib and Baricitinib
Dermatologyalopecia areataBaricitinib

Unorthodox JAK Inhibitor Dosing in Pediatric Moderate-to-Severe Alopecia Areata: A Comparative Evaluation of Tofacitinib and Baricitinib

By MedXY|Mar 5, 2026

This study of 100 pediatric patients with moderate-to-severe alopecia areata demonstrates that unorthodox dosing regimens of tofacitinib and baricitinib provide comparable efficacy and high tolerability over 24 weeks.

Prev
9 / 25
1…7891011…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles